Clinical Trial Update: Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial update on Ixekizumab for plaque psoriasis, including outcomes and withdrawal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Ixekizumab (ixekizumab)

Snippet

Sponsor: Singapore General Hospital | Conditions: Plaque Psoriasis | Phase 4 | Status: RECRUITING